Read next
8 Gene Editing/CRISPR Companies to Consider For Your Portfolio
Ten years ago, Jennifer Doudna and her colleagues published the results of a test-tube experiment on bacterial genes in the journal "Science". This paper was the beginning of an adventurous journey that led to the development of CRISPR technology.
In the past decade, CRISPR has become one of
A deep dive into the microbiome market landscape
Following on from our previous article, where we covered - what is the microbiome, how it is profiled, challenges and solutions faced and the different sub-segments of the microbiome - Gut Microbiome, Oral Microbiome, Skin Microbiome and Soil Microbiome.
In this article we will do a deep dive into the
2 companies innovating to overcome the short half-life of mRNA: is self-amplifying or endless RNA the future of mRNA vaccines?
Given the incredible growth in mRNA vaccines, it is no surprise that companies are trying to improve this technology.
mRNA technology came to the forefront in 2020 with the widespread use of mRNA vaccines for protection against the SARS-CoV2 virus. Just like any other technology, mRNA technology has its drawbacks.